Welcome to LookChem.com Sign In|Join Free

CAS

  • or

56-89-3

Post Buying Request

56-89-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56-89-3 Usage

Description

L-cystine (formula: (SCH2CH(NH2) CO2H)2), the L-form of cystine) is a covalently linked dimeric nonessential amino acid formed through the oxidation of cysteine. It is contained in many foods including eggs, meat, dairy products, and whole grains as well as in skin and hairs. L-cystine and L-methionine are the amino-acids required for wound healing and formation of epithelial tissue. It is able to stimulate the hematopoietic system and promote the formation of white and red blood cells. It can also be used as a component of parental and enteral nutrition. It can also be used for the treatment of dermatitis and protection of liver function. L-cystine is manufactured through the enzymatic conversion from DL-amino thiazoline carboxylic acid.

References

http://www.ajiaminoscience.com/products/manufactured_products/l-amino_acids/L-Cystine.aspx https://pubchem.ncbi.nlm.nih.gov/compound/L-cystine#section=Pharmacology https://en.wikipedia.org/wiki/Cystine

Chemical Properties

A white or almost white, crystalline powder, practically insoluble in water and in alcohol.

Uses

Different sources of media describe the Uses of 56-89-3 differently. You can refer to the following data:
1. L-Cystine is a non-essential amino acid for human development. L-Cystine is formed by the dimerization of two cysteines through the sulfur.
2. L-Cystine is used as an antioxidant, protecting tissues against radiation and pollution. It finds application in protein synthesis. It is required for utilization of vitamin B6 and is useful in healing burns and wounds. It is also is required by certain malignant cell lines in the culture medium as well as for the growth of certain micro-organisms. It is useful in the stimulation of hematopoietic system and promotes the formation of white and red blood cells. It is an active ingredient in medications used to treat dermatitis.
3. L-Cystine has been used in in vitro cystine solubility assay to identify potential drugs that influence cystine solubility. It is also used as a supplement of phosphate-buffered saline to slice and wash periprosthetic tissues.

General Description

This Standard Reference Material (SRM) is intended primarily for use in validating microchemical procedures for the determination of carbon, hydrogen, nitrogen, and sulfur in organic matter. SRM 143d is pure crystalline cystine supplied in a 2 g unit size. For more information, please refer to the SDS and COA.SRM 143D_cert SRM 143D _SDS

Biochem/physiol Actions

Cysteine is the source of disulfide linkages in proteins and has a role in sulfur transport. It undergoes rapid oxidation to form cystine at physiological pH. L-cystine is crucial for oxygen production and low density lipoprotein modification by arterial smooth muscle cells. It also has a role in the synthesis of glutathione.

Safety Profile

Low toxicity by ingestion. When heated to decomposition it emits toxic fumes of PO, and SOx

Purification Methods

Cystine disulfoxide impurity is removed by treating an aqueous suspension with H2S. The cystine is filtered off, washed with distilled water and dried at 100o under a vacuum over P2O5. Crystallise it by dissolving in 1.5M HCl, then adjusting to neutral pH with ammonia. Likely impurities are D-cystine, meso-cystine and tyrosine. Also purify it by dissolving it in 10% NH3 and adding gradually dilute AcOH until the point of precipitation and cooling slowly [Dughton & Harrison Acta Cryst 12 396, 402 1959.] Alternatively dissolve it in 6N NH4OH and evaporate it at room temperature for crystallisation to occur. [Chaney & Steinrauf Acta Cryst 30 711 1974, Beilstein 4 IV 3155.]

Check Digit Verification of cas no

The CAS Registry Mumber 56-89-3 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 6 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 56-89:
(4*5)+(3*6)+(2*8)+(1*9)=63
63 % 10 = 3
So 56-89-3 is a valid CAS Registry Number.
InChI:InChI=1/C3H6NO2S3/c5-3(6)2(4-7)1-9-8/h2H,1,4H2,(H,5,6)

56-89-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (C0519)  L-(-)-Cystine  >98.0%(HPLC)(N)

  • 56-89-3

  • 25g

  • 200.00CNY

  • Detail
  • TCI America

  • (C0519)  L-(-)-Cystine  >98.0%(HPLC)(N)

  • 56-89-3

  • 100g

  • 515.00CNY

  • Detail
  • TCI America

  • (C0519)  L-(-)-Cystine  >98.0%(HPLC)(N)

  • 56-89-3

  • 500g

  • 1,490.00CNY

  • Detail
  • Alfa Aesar

  • (M10350)  L-Cystine, 99%   

  • 56-89-3

  • 1kg

  • 2559.0CNY

  • Detail
  • Alfa Aesar

  • (A13762)  L-Cystine, 99%   

  • 56-89-3

  • 50g

  • 250.0CNY

  • Detail
  • Alfa Aesar

  • (A13762)  L-Cystine, 99%   

  • 56-89-3

  • 250g

  • 874.0CNY

  • Detail
  • Alfa Aesar

  • (A13762)  L-Cystine, 99%   

  • 56-89-3

  • 1000g

  • 2992.0CNY

  • Detail
  • Sigma-Aldrich

  • (49603)  L-Cystine  certified reference material, TraceCERT®

  • 56-89-3

  • 49603-100MG

  • 1,117.35CNY

  • Detail
  • Sigma-Aldrich

  • (PHR1323)  L-Cystine  pharmaceutical secondary standard; traceable to USP and PhEur

  • 56-89-3

  • PHR1323-500MG

  • 732.19CNY

  • Detail
  • Sigma-Aldrich

  • (C3300000)  Cystine  European Pharmacopoeia (EP) Reference Standard

  • 56-89-3

  • C3300000

  • 1,880.19CNY

  • Detail
  • Sigma

  • (C8755)  L-Cystine  ≥98% (TLC), crystalline

  • 56-89-3

  • C8755-100G

  • 923.13CNY

  • Detail
  • Sigma

  • (C8755)  L-Cystine  ≥98% (TLC), crystalline

  • 56-89-3

  • C8755-500G

  • 2,803.32CNY

  • Detail

56-89-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name L-cystine

1.2 Other means of identification

Product number -
Other names L-Cystine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only. Food additives -> Flavoring Agents
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56-89-3 SDS

56-89-3Synthetic route

L-Cysteine
52-90-4

L-Cysteine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With 3-bromo-2-(1-hydroxycyclohexyl)[1,2]selenazolo[2,3-a]pyridinium chloride; dihydrogen peroxide In methanol; water at 20℃; for 0.166667h;100%
With dihydrogen peroxide; sodium iodide In water at 25℃; for 1h; Cooling with ice;100%
With bis(4-methoxyphenyl)telluride; rose bengal In water; isopropyl alcohol at 0℃; for 0.833333h; Irradiation;99%
L-Cysteine
52-90-4

L-Cysteine

(R)-2-Amino-3-(4-methoxy-phenylmethanesulfinyl)-propionic acid
73243-09-1

(R)-2-Amino-3-(4-methoxy-phenylmethanesulfinyl)-propionic acid

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide; trifluorormethanesulfonic acid In trifluoroacetic acid at 0℃; for 1h;100%
(R)-9H-fluorenyl-9-methyl-L-cysteine
84888-38-0

(R)-9H-fluorenyl-9-methyl-L-cysteine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With piperidine In N,N-dimethyl-formamide for 2h;100%
S-nitroso-L-cysteine
134469-02-6, 51209-75-7

S-nitroso-L-cysteine

A

L-cystine
56-89-3

L-cystine

B

NO

NO

Conditions
ConditionsYield
With copper(II) ion In water at 25℃; Rate constant; var. conc. of Cu2+;A 100%
B n/a
(R)-S-tert-butylcysteine
2481-10-9

(R)-S-tert-butylcysteine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With Methyltrichlorosilane; 1,1'-sulfinylbisbenzene at 4℃; for 0.166667h;99%
L-Cysteine
52-90-4

L-Cysteine

H-Cys(Acm)(O)-OH
75893-05-9

H-Cys(Acm)(O)-OH

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide In trifluoroacetic acid at 0℃; for 1h;97.9%
Reaxys ID: 11465027

Reaxys ID: 11465027

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With sodium hydroxide In water at 20 - 60℃; for 2h; pH=~ 4.0;97%
With ammonia In water at 20 - 60℃; for 0.666667 - 2h; pH=~ 3.0;97%
With ammonia In water at 20 - 80℃; for 2h; pH=~ 2.3 - ~ 3.0;95%
L-Cysteine
52-90-4

L-Cysteine

N-(benzoylsulfide)benzamide
134861-13-5

N-(benzoylsulfide)benzamide

A

L-cystine
56-89-3

L-cystine

B

benzamide
55-21-0

benzamide

C

D-N-benzoylcysteine

D-N-benzoylcysteine

Conditions
ConditionsYield
In methanol; aq. phosphate buffer at 20℃; pH=7.4;A 95%
B 96%
C 80%
S-(4-methoxybenzyl)-L-cysteine
2544-31-2

S-(4-methoxybenzyl)-L-cysteine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With Methyltrichlorosilane; 1,1'-sulfinylbisbenzene at 4℃; for 0.166667h;95%
With methoxybenzene; thallium(III) trifluoroacetate In trifluoroacetic acid at 0℃; for 1h;86.7%
With methoxybenzene; thallium(III) trifluoroacetate In trifluoroacetic acid at 0℃; for 1h; Product distribution; cleavage various S-protecting groups of cystein;86.7%
S-acetamidomethyl-L-cysteine
19647-70-2

S-acetamidomethyl-L-cysteine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With Methyltrichlorosilane; 1,1'-sulfinylbisbenzene at 4℃; for 0.5h;93%
With Methyltrichlorosilane; 1,1'-sulfinylbisbenzene at 4℃; for 0.5h; Product distribution; other S-protected cysteines;93%
(R)-2-Amino-3-(4-methoxy-phenylmethanesulfinyl)-propionic acid
73243-09-1

(R)-2-Amino-3-(4-methoxy-phenylmethanesulfinyl)-propionic acid

H-Cys(Ad)-OH
59709-71-6

H-Cys(Ad)-OH

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide; trifluorormethanesulfonic acid In trifluoroacetic acid at 0℃; for 1h;92.4%
S-(4-methoxybenzyl)-L-cysteine
2544-31-2

S-(4-methoxybenzyl)-L-cysteine

(R)-2-Amino-3-(4-methoxy-phenylmethanesulfinyl)-propionic acid
73243-09-1

(R)-2-Amino-3-(4-methoxy-phenylmethanesulfinyl)-propionic acid

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide; trifluorormethanesulfonic acid In trifluoroacetic acid at 0℃; for 1h;92.2%
S-(diphenyl-4-pyridylmethyl)-L-cysteine
62982-12-1

S-(diphenyl-4-pyridylmethyl)-L-cysteine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
In hydrogenchloride; acetic acid at 0℃; for 0.75h; electrolysis (mercury cathode, 250 mA);91%
S-benzyloxymethylcysteine
123043-33-4

S-benzyloxymethylcysteine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With methoxybenzene; thallium(III) trifluoroacetate In trifluoroacetic acid88.8%
With methoxybenzene; thallium(III) trifluoroacetate In trifluoroacetic acid Product distribution; other reagent;88.8%
S-Trimethylacetamidomethyl-L-cysteine (H-Cys(Tacm)OH)
125700-47-2

S-Trimethylacetamidomethyl-L-cysteine (H-Cys(Tacm)OH)

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With Methyltrichlorosilane; 1,1'-sulfinylbisbenzene at 4℃; for 0.5h;88%
With iodine In acetic acid at 25℃; for 1h;83%
With iodine In acetic acid at 25℃; for 1h; stability of protecting group under various conditions, various reagents, other substrates;83%
H-Cys(Ad)-OH
59709-71-6

H-Cys(Ad)-OH

H-Cys(Acm)(O)-OH
75893-05-9

H-Cys(Acm)(O)-OH

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide; trimethylsilyl trifluoromethanesulfonate In trifluoroacetic acid at 0℃; for 1h;86.3%
S-(4-methoxybenzyl)-L-cysteine
2544-31-2

S-(4-methoxybenzyl)-L-cysteine

H-Cys(Acm)(O)-OH
75893-05-9

H-Cys(Acm)(O)-OH

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide In trifluoroacetic acid at 25℃; for 1h;85.3%
N-t-butoxycarbonyl-S-acetamidomethyl-L-cysteine
19746-37-3

N-t-butoxycarbonyl-S-acetamidomethyl-L-cysteine

A

L-cystine
56-89-3

L-cystine

B

S-acetamidomethyl-L-cysteine
19647-70-2

S-acetamidomethyl-L-cysteine

Conditions
ConditionsYield
With Methyltrichlorosilane; 1,1'-sulfinylbisbenzene; trifluoroacetic acid at 4℃; for 0.166667h; Product distribution; Mechanism; var. reaction times, silyl chlorides and sulfoxides; other S-protected cystine-peptides;A 79%
B 15%
S-Benzamidomethyl-L-cystein
57357-62-7

S-Benzamidomethyl-L-cystein

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With Methyltrichlorosilane; 1,1'-sulfinylbisbenzene at 4℃; for 0.5h;76%
S-<(4-methylphenyl)methyl>-L-cysteine
42294-52-0

S-<(4-methylphenyl)methyl>-L-cysteine

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With Methyltrichlorosilane; 1,1'-sulfinylbisbenzene at 4℃; for 0.166667h;49%
With dimethyl sulfoxide; methoxybenzene; trifluoroacetic acid Ambient temperature;
(+)-D-glucosamine hydrochloride
1078691-95-8

(+)-D-glucosamine hydrochloride

A

L-cystine
56-89-3

L-cystine

B

2-(D-arabino-1',2',3',4'-tetrahydroxybutyl)-5-(D-erythro-2
17460-13-8

2-(D-arabino-1',2',3',4'-tetrahydroxybutyl)-5-(D-erythro-2",3",4"-trihydroxybutyl)piperazine

Conditions
ConditionsYield
With pyridine; l-cysteine hydrochloride In methanol; water for 32h; Heating;A n/a
B 45%
Boc-Cys(Acm)(O)-OH
75893-04-8

Boc-Cys(Acm)(O)-OH

phenol
108-95-2

phenol

A

L-cystine
56-89-3

L-cystine

B

S-(4-hydroxyphenyl)-L-cysteine
73243-10-4

S-(4-hydroxyphenyl)-L-cysteine

Conditions
ConditionsYield
With hydrogenchloride at 110℃; for 24h;A 16%
B 41%
H-Cys(Acm)(O)-OH
75893-05-9

H-Cys(Acm)(O)-OH

A

L-Cysteine
52-90-4

L-Cysteine

B

L-Cysteic acid
498-40-8

L-Cysteic acid

C

L-cystine
56-89-3

L-cystine

D

S-acetamidomethyl-L-cysteine
19647-70-2

S-acetamidomethyl-L-cysteine

Conditions
ConditionsYield
With ammonia; sodium for 0.00277778h; Product distribution;A n/a
B 19%
C 10%
D 21%
L-Cysteine
52-90-4

L-Cysteine

(R)-3-(Adamantane-1-sulfinyl)-2-amino-propionic acid

(R)-3-(Adamantane-1-sulfinyl)-2-amino-propionic acid

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide; trifluorormethanesulfonic acid In trifluoroacetic acid at 0℃; for 1h;20.8%
S-(4-methoxybenzyl)-L-cysteine
2544-31-2

S-(4-methoxybenzyl)-L-cysteine

(R)-3-(Adamantane-1-sulfinyl)-2-amino-propionic acid

(R)-3-(Adamantane-1-sulfinyl)-2-amino-propionic acid

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide; trifluorormethanesulfonic acid In trifluoroacetic acid at 0℃; for 1h;15.5%
H-Cys(Ad)-OH
59709-71-6

H-Cys(Ad)-OH

(R)-3-(Adamantane-1-sulfinyl)-2-amino-propionic acid

(R)-3-(Adamantane-1-sulfinyl)-2-amino-propionic acid

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With dimethylsulfide; trifluorormethanesulfonic acid In trifluoroacetic acid at 0℃; for 1h;10.5%
L-serin
56-45-1

L-serin

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
im Organismus der Ratte;
L-cystine
56-89-3

L-cystine

methyl chloroformate
79-22-1

methyl chloroformate

(R,R)-N,N'-dimethoxycarbonyl-3,3'-dithiobis(2-aminopropionic acid)
78589-87-4

(R,R)-N,N'-dimethoxycarbonyl-3,3'-dithiobis(2-aminopropionic acid)

Conditions
ConditionsYield
With sodium hydroxide; sodium carbonate at 20℃; for 2h; pH=8 - 9;100%
With sodium carbonate In tetrahydrofuran; water at 20℃; for 16h;65%
L-cystine
56-89-3

L-cystine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

di-t-butoxycarbonyl-L-cystine
10389-65-8

di-t-butoxycarbonyl-L-cystine

Conditions
ConditionsYield
With sodium carbonate In 1,4-dioxane; water at 20℃;100%
With triethylamine In water Cooling with ice;96%
With triethylamine In water at 20℃; for 2h;95%
L-cystine
56-89-3

L-cystine

toluene-4-sulfonic acid
104-15-4

toluene-4-sulfonic acid

allyl alcohol
107-18-6

allyl alcohol

L-cystine-bis-allyl ester bis-(toluene-4-sulfonate)

L-cystine-bis-allyl ester bis-(toluene-4-sulfonate)

Conditions
ConditionsYield
In benzene at 90℃; for 16h;100%
In benzene for 12h; Esterification; Heating;95%
methanol
67-56-1

methanol

L-cystine
56-89-3

L-cystine

L-cystine dimethyl ester dihydrochloride
32854-09-4

L-cystine dimethyl ester dihydrochloride

Conditions
ConditionsYield
With chloro-trimethyl-silane100%
With thionyl chloride at 25℃; for 24h; Schlenk technique; Inert atmosphere;99%
With thionyl chloride for 20h; Reflux;98%
L-cystine
56-89-3

L-cystine

benzyl chloroformate
501-53-1

benzyl chloroformate

N,N'-bis(benzyloxycarbonyl)-L-cystine
6968-11-2

N,N'-bis(benzyloxycarbonyl)-L-cystine

Conditions
ConditionsYield
With sodium hydrogencarbonate In water at 20℃;99%
Stage #1: L-cystine; benzyl chloroformate With sodium hydroxide In tetrahydrofuran; water at 20℃; for 3.25h; pH=10; Cooling with ice; Inert atmosphere;
Stage #2: With hydrogenchloride In water pH=2; Inert atmosphere;
98%
With sodium hydroxide at 0℃; for 4h;72%
L-cystine
56-89-3

L-cystine

L-Cysteine
52-90-4

L-Cysteine

Conditions
ConditionsYield
With ethandithiol at 40℃; for 5h; pH=7.5 adjusted with 5 percent NH4OH;98.5%
With ammonia; sodium Reduction;90%
With hydrogenchloride; tin man verduennt die Loesung, befreit sie mit H2S vom Zinn, verdunstet zur Trockne, loest den Rueckstand in Alkohol und faellt vorsichtig mit Ammoniak;
methanol
67-56-1

methanol

L-cystine
56-89-3

L-cystine

L-cystine dimethyl ester
1069-29-0

L-cystine dimethyl ester

Conditions
ConditionsYield
With thionyl chloride for 12.5h; Cooling with ice;98%
With hydrogenchloride man zersetzt das Hydrochlorid mit Natriummethylat;
With thionyl chloride
With thionyl chloride at 0℃; for 12h; Inert atmosphere; Reflux;
With thionyl chloride at 0℃; for 12h; Reflux;12.4 g
L-cystine
56-89-3

L-cystine

chloroformic acid ethyl ester
541-41-3

chloroformic acid ethyl ester

(R,R)-N,N'-diethoxycarbonyl-3,3'-dithiobis(2-aminopropionic acid)
19887-39-9

(R,R)-N,N'-diethoxycarbonyl-3,3'-dithiobis(2-aminopropionic acid)

Conditions
ConditionsYield
With sodium hydroxide; sodium carbonate at 20℃; for 1.5h; pH=8 - 9;98%
With sodium hydroxide98%
L-cystine
56-89-3

L-cystine

(fluorenylmethoxy)carbonyl chloride
28920-43-6

(fluorenylmethoxy)carbonyl chloride

N,N'-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-cystine
135273-01-7

N,N'-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-cystine

Conditions
ConditionsYield
With sodium carbonate In 1,4-dioxane; water at 10 - 20℃; for 2h;98%
Stage #1: L-cystine With sodium hydroxide In tetrahydrofuran; water pH=10;
Stage #2: (fluorenylmethoxy)carbonyl chloride In tetrahydrofuran; water at 0℃; for 3h; pH=10;
L-cystine
56-89-3

L-cystine

nickel(II)

nickel(II)

Ni(L-cystinate) * H2O

Ni(L-cystinate) * H2O

Conditions
ConditionsYield
With sodium hydroxide In perchloric acid mixing stoich. amts. of metal (in H2O) and ligand (in 0.2 M HClO4), pH adjustment to 7-8 with NaOH (boiling, pptn.); filtration, washing (H2O, EtOH, ether); elem. anal.;97.7%
L-cystine
56-89-3

L-cystine

zinc(II) cation

zinc(II) cation

Zn(L-cystinate) * H2O

Zn(L-cystinate) * H2O

Conditions
ConditionsYield
With sodium hydroxide In perchloric acid mixing stoich. amts. of metal (in H2O) and ligand (in 0.2 M HClO4), pH adjustment to 7-8 with NaOH (room temp., pptn.); filtration, washing (H2O, EtOH, ether); elem. anal.;96%
L-cystine
56-89-3

L-cystine

copper(II) ion

copper(II) ion

Cu(L-cystinate) * 1/2 H2O

Cu(L-cystinate) * 1/2 H2O

Conditions
ConditionsYield
With sodium hydroxide In perchloric acid mixing stoich. amts. of metal (in H2O) and ligand (in 0.2 M HClO4), pH adjustment to 7-8 with NaOH (room temp., pptn.); filtration, washing (H2O, EtOH, ether); elem. anal.;95.2%
L-cystine
56-89-3

L-cystine

benzyl pyridin-2-yl carbonate
96452-48-1

benzyl pyridin-2-yl carbonate

N,N'-bis(benzyloxycarbonyl)-L-cystine
6968-11-2

N,N'-bis(benzyloxycarbonyl)-L-cystine

Conditions
ConditionsYield
With triethylamine In water; N,N-dimethyl-formamide for 1h; Ambient temperature;95%
L-cystine
56-89-3

L-cystine

Allyl chloroformate
2937-50-0

Allyl chloroformate

N,N-Bis-allyloxycarbonyl-L-cystine
80349-71-9

N,N-Bis-allyloxycarbonyl-L-cystine

Conditions
ConditionsYield
With potassium hydroxide; water; sodium carbonate at 20℃; for 48h; Acylation;95%
L-cystine
56-89-3

L-cystine

lead(2+) cation

lead(2+) cation

Pb(L-cystinate)

Pb(L-cystinate)

Conditions
ConditionsYield
With sodium hydroxide In perchloric acid mixing stoich. amts. of metal (in H2O) and ligand (in 0.2 M HClO4), pH adjustment to 7-8 with NaOH (room temp., pptn.); filtration, washing (H2O, EtOH, ether); elem. anal.;95%
With NaHCO3 In water treatment of aq. soln. of L-cystine with NaHCO3 soln., heating with Pb(II) salts at 50-60°C in water bath for about 1/2 h; cooling, crystn. at room temp., filtration, washing with cold H2O, drying over silica gel in a desiccator; elem. anal.;
L-cystine
56-89-3

L-cystine

A

L-Cysteine
52-90-4

L-Cysteine

B

L-Cysteic acid
498-40-8

L-Cysteic acid

Conditions
ConditionsYield
With hydrogenchloride; sulfuric acid; hydrogen bromide In water at 45℃; electrolysis (graphite sheets, i = 0.5 A/cm2);A 94%
B n/a
With hydrogenchloride; sulfuric acid; hydrogen bromide In water at 45℃; Product distribution; Mechanism; paired electrosynthesis (graphite sheets, i = 0.5 A/cm2);A n/a
B 94%
With hydrogenchloride at 40℃; Electrolysis;
L-cystine
56-89-3

L-cystine

copper(II) ion

copper(II) ion

Cu(L-cystinate) * H2O

Cu(L-cystinate) * H2O

Conditions
ConditionsYield
With sodium hydroxide In perchloric acid mixing stoich. amts. of metal (in H2O) and ligand (in 0.2 M HClO4), pH adjustment to 7-8 with NaOH (boiling, pptn.); filtration, washing (H2O, EtOH, ether); elem. anal.;94%
L-cystine
56-89-3

L-cystine

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide
82911-69-1

N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide

N,N'-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-cystine
135273-01-7

N,N'-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-cystine

Conditions
ConditionsYield
With sodium carbonate In water; acetone at 50℃;94%
With sodium carbonate In tetrahydrofuran; water at 20℃; Cooling with ice;

56-89-3Relevant articles and documents

A REINVESTIGATION OF THE OXIDATION OF CYSTEINE BY Br2(1-)(.) AND I2(1-)(.). EVIDENCE FOR CySBr(1-) AND CySI(1-).

Packer, John E.

, p. 1015 - 1024 (1984)

The existence of the species CySBr(1-) and CySI(1-), which may be regarded as complexes between the thiyl radical from cysteine and bromide or iodide ions, is reported, and their properties discussed in relation to other sulphur- and halogen- containing species which also, have a three-electron half-order bond.The oxidation of cysteine by I2(1-)(.) is shown to be much more complex than hitherto reported, and pH-dependent equilibria involving iodine atoms, iodide ions, cysteine, and cysteinyl radicals are described.The first measured rate constant for the reaction of iodine (as I3(1-)) with a thiol is also reported.

Hierarchical cystine flower based electrochemical genosensor for detection of Escherichia coli O157:H7

Pandey, Chandra Mouli,Tiwari, Ida,Sumana, Gajjala

, p. 31047 - 31055 (2014)

This work reports on a facile and reproducible approach to synthesize novel organic flowers of cystine (CysFls) with high uniformity. These 3D flower-like structures have a purely hierarchical arrangement, wherein each petal is composed of several cystine molecules with an average size of 50 μM, as determined by transmission electron microscopy. The CysFls were self-assembled onto a gold electrode and were utilized as matrices for the covalent immobilization of an Escherichia coli O157:H7 (E. coli) specific probe oligonucleotide that was identified from the 16s rRNA coding region of the E. coli genome. This fabricated CysFl platform sought to provide improved fundamental characteristics to electrode interface in terms of electro-active surface area and diffusion coefficient. Electrochemical impedance spectroscopy revealed that this genosensor exhibits a linear response to complementary DNA in the concentration range of 10-6 to 10-15 M with a detection limit of 1 × 10-15 M. Under optimal conditions, this genosensor was found to retain about 88% of its initial activity after being used for 6 times. This journal is the Partner Organisations 2014.

Simple and facile preparation of silver-polydopamine (Ag-PDA) core-shell nanoparticles for selective electrochemical detection of cysteine

Thota, Raju,Ganesh

, p. 49578 - 49587 (2016)

Selective and sensitive non-enzymatic electrochemical detection of cysteine (CySH) is achieved in the present work using a polydopamine capped silver nanoparticles (Ag-PDA) modified indium tin oxide (ITO) electrode. Efficient redox properties, synergistic effects and the specific steric hindrance associated with the Ag-PDA core-shell nanoparticles provide higher selectivity and larger sensitivity for CySH detection over other competitive bio-thiols namely, homo-cysteine and glutathione. A simple one-step method is used for the preparation of Ag-PDA core-shell nanoparticles. The structure, morphology and composition of Ag-PDA nanoparticles are characterized by using field emission scanning electron microscopy (FESEM), transmission electron microscopy (TEM), X-ray diffraction (XRD), X-ray photoelectron spectroscopy (XPS), UV-visible (UV-vis) and Fourier transform infra red (FTIR) spectroscopic techniques. Electrochemical characteristics are investigated by using cyclic voltammetry (CV) and linear sweep voltammetry (LSV). These studies clearly reveal the formation of Ag-PDA nanocomposite on the ITO electrodes and their corresponding redox properties. Non-enzymatic electrochemical detection of CySH is carried out using Ag-PDA modified ITO electrodes in 0.1 M PBS (pH = 5.0) aqueous solution. Under the optimized conditions, this particular electrochemical biosensor exhibits a perfect linear calibration plot in the concentration range between 0.05 μM and 300 μM. Further, a sensitivity value of 0.023 μA μM-1 and a lower detection limit of 0.02 μM are determined for CySH detection. Moreover this Ag-PDA modified ITO electrode is applied further for the determination of CySH in human blood serum samples and the results are promising and satisfactory, suggesting the possible analytical application of this biosensor for the determination of CySH in biological samples.

An unusual electrochemical oxidation of phenothiazine dye to phenothiazine-bi-1,4-quinone derivative (a donor-acceptor type molecular hybrid) on MWCNT surface and its cysteine electrocatalytic oxidation function

Shanmugam, Ranganathan,Barathi, Palani,Zen, Jyh-Myng,Kumar, Annamalai Senthil

, p. 34 - 45 (2016)

Phenothiazine (PTZ), a thiazine class heterocyclic compound, is a well-known electron donating system and has been widely used as a starting compound to prepare various phenothiazine dyes and pharmaceutically important compounds. Quinones and its derivatives are constituents of biologically active molecules serve as excellent electron-acceptor systems. Oxidation of PTZ by chemical and electrochemical methods often resulted into monohydroxylation of benzene ring moiety, S-oxidized and polymerized compounds as end products. Electrochemical oxidation of PTZ on a multiwalled carbon nanotube (MWCNT) modified glassy carbon electrode in pH 7 phosphate buffers solution (PBS) has been investigated in this work. A highly redox active surface confined PTZ-bi-1,4-quinone derivative (PTZ-biQ) on MWCNT modified glassy carbon electrode, designated as GCE/MWCNT@PTZ-biQ, as a product was unusually observed. The GCE/MWCNT@PTZ-biQ showed well-defined redox peaks at E1/2 = -0.07 and +0.29 V vs Ag/AgCl corresponding to surface confined electron-transfer behavior of the bi-quinone (acceptor) and PTZ-cationic radical species (donor) respectively. No such electrochemical characteristics were noticed when unmodified GCE was subjected to the electrochemical oxidation of PTZ. Existence of PTZ-biQ was confirmed by XRD, Raman spectroscopy, FT-IR and GC-MS (methanolic extract of the active layer) analyses. Position of biQ in PTZ-biQ as 1,4-quinone isomer was confirmed by observation of absence of copper-complexation with 1,4-quinone and H2O2 electrochemical reduction reactions at -0.1 V vs Ag/AgCl unlike to the specific copper-complexation and H2O2 reduction with 1,2-quinone isomer in pH 7. Cysteine (CySH) oxidation was studied as a model system to understand the electron-transfer function of the MWCNT@PTZ-biQ. A highly selective electrocatalytic oxidation and sensing by amperometric i-t and flow injection analysis of CySH at low oxidation potential, 0.3 V vs Ag/AgCl in pH 7 PBS with detection limit values (signal-to-noise ratio = 3) of 11.10 μM and 110 nM respectively, without any interference from other biochemicals like uric acid, dopamine, nitrite, citric acid and H2O2, unlike the conventional chemically modified electrodes with serious interference's, have been demonstrated.

Utzinger

, (1960)

A cytotoxic tantalum(v) half-sandwich complex: A new challenge for metal-based anticancer agents

?tarha, Pavel,Trávní?ek, Zdeněk,Dvo?ák, Zdeněk

, p. 9533 - 9536 (2018)

Despite the biological relevance of complexes of various transition metals, tantalum complexes have long been neglected by bioinorganic chemists. Herein, we demonstrate potential chemotherapeutic applicability of the [Ta(η5-Cp?)Cl2(salaph)] (1) complex, containing deprotonated Schiff base 2-{(E)-[(2-hydroxyphenyl)imino]methyl}phenol (H2salaph), which shows strong cytotoxicity in cancer cells, related to the induction of apoptosis and apoptosis-related processes, but shows low cytotoxicity in healthy cells.

Redox Chemistry of [Fe2(CN)10]4-. Part 4 Reaction with L-Cysteine

Beckford, Floyd A.,Bennet, Deon,Dasgupta, Tara P.,Stedman, Geoffrey

, p. 98 - 99 (1998)

L-Cysteine reduces [Fe2(CN)10]4- to [Fe2(CN)10]6- in a two stage process, a rapid reduction to [Fe2(CN)10]6- followed by a slower second order reaction involving HSCH2CH (NH3+CO2- and a conjugate base.

Synthesis of Cystine-peptide by a New Disulphide Bond-forming Reaction using the Silyl Chloride-Sulphoxide System

Akaji, Kenichi,Tatsumi, Tadashi,Yoshida, Makoto,Kimura, Tooru,Fujiwara, Yoichi,Kiso, Yoshiaki

, p. 167 - 168 (1991)

Methyltrichlorosilane or tetrachlorosilane in trifluoroacetic acid, in the presence of diphenylsulphoxide, is found to cleave various S-protecting groups of cysteine to form cystine directly by the reduction-oxidation reaction; this new disulphide bond forming reaction is successfully applied to the syntheses of oxytocin and human brain natriuretic peptide.

A simple and efficient fluorescent sensor for histidine

Huang, Zeng,Du, Jiao,Zhang, Jing,Yu, Xiao-Qi,Pu, Lin

, p. 3412 - 3414 (2012)

A simple coordination complex terpyridine-CuCl2 is found to be an efficient fluorescent sensor for histidine in aqueous solution with up to 1004 fold fluorescence enhancement.

Adduct Formation and Absolute Rate Constants in the Displacement Reaction of Thiyl Radicals with Disulfides

Bonifacic, M.,Asmus, K.-D.

, p. 6286 - 6290 (1984)

The displacement reaction of thiyl radicals with disulfides is shown to proceed via a transient adduct radical by using time-resolved pulse radiolysis techniques.The relatively long-lived adduct (t1/2 > 100 μs) formed in the forward reaction of the equilibrum RS. + RSSR . is suggested to be a sulfuranyl radical with the unpaired electron located in an antibonding ?* orbital within a trisulfide bridge.These species exhibit optical absorptions in the UV, e.g., λmax = 375 +/- 10 nm and ε = (3.4 +/- 0.4)*103 M-1 cm-1 for the all-methylated radical, and have been identified in aqueous and methanolic solutions.Equilibrum constants of K = 180 +/- 30 and 60 +/- 20 M-1 have been evaluated for the systems with R = CH3 and cysteine residue, respectively, via two different methods.The corresponding forward reactions occur with k(RS. + RSSR) = 3.8*106 and 7.7*105 M-1 s-1, respectively.

Formation, characterization and electrochemical properties of novel tetrasubstituted cobalt phthalocyanines bearing tetrahydropyran, furan and coumarin moieties

Chohan, Sumayya,Booysen, Irvin Noel,Mambanda, Allen,Akerman, Matthew Piers

, p. 183 - 191 (2016)

Cobalt phthalocyanines (CoPcs) bearing peripherally tetrasubstituted tetrahydropyran (thp) or furan (fur) moieties were formed and spectroscopically characterized. Structural elucidations of 4-(tetrahydropyran-2-methoxy)phthalonitrile (1) and 4-(furan-2-methylthio)phthalonitrile (2) were confirmed via single crystal X-ray analysis. The redox properties of CoPc-thp (3) and CoPc-fur (4) were investigated via cyclic and squarewave voltammetry as well as UV-Vis spectroelectrochemistry. Glassy carbon electrodes (GCEs) modified with 3, 4 and a previously reported coumarin (cou) substituted CoPc (CoPc-cou, 5), were tested for their electrocatalytic activities toward l-cysteine. While the bare GCE and 4-GCE showed no peaks for l-cysteine oxidation in the 0.0-0.70 V potential window; 3-GCE and 5-GCE showed peaks at 0.42 V and 0.52 V, respectively. Kinetic parameters were determined by chronoamperometry studies. l-Cysteine oxidation using 3-GCE was found to proceed at a faster rate than 5-GCE.

Iron(III)–salen ion catalyzed s-oxidation of L-cysteine and s-alkyl-L-cysteines by H2O2: Spectral, kinetic and electrochemical study

Karuppasamy, Periyakaruppan,Thiruppathi, Dharmaraj,Ganesan, Muniyandi,Rajendran, Thangamuthu,Rajagopal, Seenivasan,Sivasubramanian, Veluchamy Kamaraj

, p. 135 - 145 (2019)

The H2O2 oxidation of L-cysteine and s-alkyl-L-cysteines (s-met-L-cys, s-et-L-cys & s-pro-L-cys) catalyzed by iron(III)–salen (salen = N,N′-bis(salicylidene)ethylenediaminato) complexes in aqueous CH3CN proceeds through Michaelis–Menten kinetics. The rate constant (k) values correlate well with Hammett σ constants, which gives the positive reaction constant (ρ = 1.5–1.9) value. The CV of oxoiron(IV)-salen ion shows a clear oxidation peak at 1.28 V in 0.1 M phosphate buffer (PB) solution using 0.1 M tertiary butyl ammonium perchlorate (TBAP) as supporting electrolyte at 266 K. The rate of the reaction is highly sensitive to the length of the alkyl chains present in the L-cysteines, pH and solvent composition of the medium. The calculated binding constant values (Kf) in the range of 117–613 M?1, indicate that iron(III)–salen complexes carrying electron donating substituents in the salen ligand have higher binding constant values compared to those carrying electron withdrawing substituents. Product analysis shows the conversion of L-cys to its disulfide and s-alkyl-L-cys to the corresponding sulfoxides. Based on the spectral and kinetic data the plausible mechanism has been proposed.

Determination of a small quantity of cystine in the presence of a large amount of cysteine

Yamagata, Shuzo,Iwama, Tomonori

, p. 1503 - 1505 (1999)

A procedure is described to precisely determine a very small amount of cystine in the presence of a large amount of cysteine. After completely modifying cysteine with N-ethylmaleimide, the remaining reagent was reacted with DL-homocysteine. Cystine was determined, after being reduced with dithiothreitol, by the reaction with ninhydrin carried out under acidic conditions. The procedure makes it possible to precisely determine the amount of cystine present with cysteine in a concentration ratio of 1:2,000. By employing this procedure, auto-oxidation of cysteine to cystine in a mixture for the L-cysteine α, β-elimination reaction was investigated.

Reduction of RuVI≡N to RuIII - NH3 by Cysteine in Aqueous Solution

Wang, Qian,Man, Wai-Lun,Lam, William W. Y.,Yiu, Shek-Man,Tse, Man-Kit,Lau, Tai-Chu

, p. 5850 - 5858 (2018)

The reduction of metal nitride to ammonia is a key step in biological and chemical nitrogen fixation. We report herein the facile reduction of a ruthenium(VI) nitrido complex [(L)RuVI(N)(OH2)]+ (1, L = N,N′-bis(salicylidene)-o-cyclohexyldiamine dianion) to [(L)RuIII(NH3)(OH2)]+ by l-cysteine (Cys), an ubiquitous biological reductant, in aqueous solution. At pH 1.0-5.3, the reaction has the following stoichiometry: [(L)RuVI(N)(OH2)]+ + 3HSCH2CH(NH3)CO2 → [(L)RuIII(NH3)(OH2)]+ + 1.5(SCH2CH(NH3)CO2)2. Kinetic studies show that at pH 1 the reaction consists of two phases, while at pH 5 there are three distinct phases. For all phases the rate law is rate = k2[1][Cys]. Studies on the effects of acidity indicate that both HSCH2CH(NH3+)CO2- and -SCH2CH(NH3+)CO2- are kinetically active species. At pH 1, the reaction is proposed to go through [(L)RuIV(NHSCH2CHNH3CO2H)(OH2)]2+ (2a), [(L)RuIII(NH2SCH2CHNH3CO2H)(OH2)]2+ (3), and [(L)RuIV(NH2)(OH2)]+ (4) intermediates. On the other hand, at pH around 5, the proposed intermediates are [(L)RuIV(NHSCH2CHNH3CO2)(OH2)]+ (2b) and [(L)RuIV(NH2)(OH2)]+ (4). The intermediate ruthenium(IV) sulfilamido species, [(L)RuIV(NHSCH2CHNH3CO2H)(OH2)]2+ (2a) and the final ruthenium(III) ammine species, [(L)RuIII(NH3)(MeOH)]+ (5) (where H2O was replaced by MeOH) have been isolated and characterized by various spectroscopic methods.

Kinetic Studies of the Oxidation of Thiols by Coenzyme PQQ

Itoh, Shinobu,Kato, Noboyuki,Mure, Minae,Ohshiro, Yoshiki

, p. 420 - 422 (1987)

Kinetic studies on the oxidation of thiols by coenzyme PQQ are carried out under anaerobic conditions.A bell-shaped pH-rate profile having a maximum rate at around pKa of the thiol is observed.The rate-determining step changes between acidic and basic sides of the profile indicating the existence of at least one intermediate in the course of the reaction.

Real-time monitoring of "self-oxidation" of cysteine in presence of Cu2+: novel findings in the oxidation mechanism

Buzuk, Marijo,Brini?, Slobodan,Vladislavi?, Nives,Brali?, Marija,Buljac, Ma?a,Ron?evi?, Ivana ?kugor

, p. 359 - 367 (2016)

A novel approach for investigation of a mechanism and rate of "self-oxidation" of cysteine in the presence of Cu2+ is presented. Continuous monitoring was performed using simple, low-cost, and widely available commercial ion-selective electrode for Cu2+. Presented procedure provides a complete real-time picture of overall oxidation process and has revealed a sequentially organized process, with the domination of certain reactions in each stage. A plausible mechanism, in the light of the previously reported explanation, has been proposed to account for the experimental results together with an adequate scheme of the overall process. The dependence of both the pH (measurements were performed at pH 5, 7, 8) and the concentration of the initially present Cu2+ is presented and discussed. Additionally, information into the process was collected by experiments performed in oxygen-free atmosphere and changes in the mechanism of oxidation, at weakly alkaline pH values, were observed. Information presented in this study can be utilized in advanced biochemical monitoring systems, when considering the importance of the position of cysteine and cysteine containing peptides in metabolic processes.

COPPER-CATALYZED AUTOXIDATION OF CYSTEINE. THE AMOUNT OF HYDROGEN PEROXIDE PRODUCED UNDER VARIOUS CONDITIONS AND THE STOICHIOMETRY OF THE REACTION.

Hanaki,Kamide

, p. 2065 - 2068 (1983)

Hydrogen peroxide is shown to be produced as an intermediate from oxygen in the copper-catalyzed autoxidation of cysteine. The amounts of cysteine oxidized and of hydrogen peroxide formed varied depending on the reaction conditions employed. The peroxide upon forming was spontaneously utilized for the oxidation of cysteine. As a result, the ratio of the concentration of hydrogen peroxide formed to cysteine oxidized is variable depending on the conditions. But, in dilute solutions, where the oxidation by the peroxide was slow, a stoichiometric relation of 2:1 was obtained between cysteine consumed and hdyrogen peroxide produced. The rate of autoxidation is dependent on the concentration of oxygen dissolved. The double reciprocal plot of the rate against the concentration of oxygen gives a straight line, which indicates a possibility of the Michaelis-Menten type mechanism concerning the reoxidation or oxygenation of Cu(I) species.

Metal organic frameworks as nitric oxide catalysts

Harding, Jacqueline L.,Reynolds, Melissa M.

, p. 3330 - 3333 (2012)

The use of metal organic frameworks (MOFs) for the catalytic production of nitric oxide (NO) is reported. In this account we demonstrate the use of Cu 3(BTC)2 as a catalyst for the generation of NO from the biologically occurring substrate, S-nitrosocysteine (CysNO). The MOF catalyst was evaluated as an NO generator by monitoring the evolution of NO in real time via chemiluminescence. The addition of 2, 10, and 15-fold excess CysNO to MOF-CuII sites and cysteine (CysH) resulted in catalytic turnover of the active sites and nearly 100% theoretical yield of the NO product. Control experiments without the MOF present did not yield appreciable NO generation. In separate studies the MOF was found to be reusable over successive iterations of CysNO additions without loss of activity. Subsequently, the MOF catalyst was confirmed to remain structurally intact by pXRD and ATR-IR following reaction with CysNO and CysH.

Reduction of vanadium(IV) to vanadium(III) by cysteine methyl ester in water in the presence of amino polycarboxylates

Kanamori, Kan,Kinebuchi, Yoshiko,Michibata, Hitoshi

, p. 423 - 424 (1997)

The reduction behavior of vanadium(IV) by several thiolate compounds in water was investigated in the presence of amino polycarboxylates. Vanadium(IV) can be reduced by cysteine methyl ester in the presence of edta or cydta to yield [VIII(edta or cydta)(H20)]-, respectively.

Reduction of an asymmetric Pt(IV) prodrug fac-[Pt(dach)Cl3(OC(=O)CH3)] by biological thiol compounds: kinetic and mechanistic characterizations

Huo, Shuying,Ma, Dongying,Song, Changying,Sun, Jingjing,Wang, Yafang

, p. 623 - 631 (2021/11/22)

An asymmetric Pt(IV) prodrug fac-[Pt (dach)Cl3(OC(=O)CH3)] (dach = 1,2-diaminocyclohexane) was synthesized, and the reduction of the Pt(IV) prodrug by three biological thiols glutathione (GSH), cysteine (Cys) and homocysteine (Hcy) was investigated by a stopped-flow spectrometer. All the reductions were followed by an overall second-order reaction with first-order in both [Pt(IV)] and [thiol]. The reduction of the Pt(IV) prodrug occurred through a chloride bridge (Pt-Cl-S) mediated two electron transfer process. Therefore, the coordinated chloride possesses a better bridging effect than the oxygen atom from the coordinated –CH3COO? of the Pt(IV) prodrug. A reactivity trend of k′Cys > k′GSH > k′Hcy is found, illustrating that the reactivity is followed by the trend of Cys > GSH > Hcy in pH 7.4 buffer. Graphical abstract: Transition state is formed between the axially coordinated chloride of the platinum(IV) complex and the sulfur atom from the thiol/thiolate group of Cys/Hcy/GSH.[Figure not available: see fulltext.].

Enhanced Light-Driven Hydrogen Production by Self-Photosensitized Biohybrid Systems

Martins, Mónica,Toste, Catarina,Pereira, Inês A. C.

supporting information, p. 9055 - 9062 (2021/03/15)

Storage of solar energy as hydrogen provides a platform towards decarbonizing our economy. One emerging strategy for the production of solar fuels is to use photocatalytic biohybrid systems that combine the high catalytic activity of non-photosynthetic microorganisms with the high light-harvesting efficiency of metal semiconductor nanoparticles. However, few such systems have been tested for H2 production. We investigated light-driven H2 production by three novel organisms, Desulfovibrio desulfuricans, Citrobacter freundii, and Shewanella oneidensis, self-photosensitized with cadmium sulfide nanoparticles, and compared their performance to Escherichia coli. All biohybrid systems produced H2 from light, with D. desulfuricans-CdS demonstrating the best activity overall and outperforming the other microbial systems even in the absence of a mediator. With this system, H2 was continuously produced for more than 10 days with a specific rate of 36 μmol gdcw?1 h?1. High apparent quantum yields of 23 % and 4 % were obtained, with and without methyl viologen, respectively, exceeding values previously reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56-89-3